Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 CHEST指南：肺癌筛查

2018-04-01 美国胸科医师学会 Chest. 2018 Apr;153(4):954-985.

肺癌筛查

再过去的几年里，低剂量胸部CT检查已经成为美国肺癌筛查的一种标准的措施。本文基于低剂量胸部CT筛查的风险，获益以及适应证更新的相关证据，并依据最新证据提出了肺癌筛查的建议。

中文标题：

2018 CHEST指南：肺癌筛查

英文标题：

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

发布机构：

美国胸科医师学会

发布日期：

2018-04-01

简要介绍：

再过去的几年里，低剂量胸部CT检查已经成为美国肺癌筛查的一种标准的措施。本文基于低剂量胸部CT筛查的风险，获益以及适应证更新的相关证据，并依据最新证据提出了肺癌筛查的建议。

 

拓展指南：与肺癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CHEST指南：肺癌筛查)] GetToolGuiderByIdResponse(projectId=1, id=81c7e1c001582a21, title=2018 CHEST指南：肺癌筛查, enTitle=Screening for Lung Cancer: CHEST Guideline and Expert Panel Report., guiderFrom=Chest. 2018 Apr;153(4):954-985., authorId=null, author=, summary=再过去的几年里，低剂量胸部CT检查已经成为美国肺癌筛查的一种标准的措施。本文基于低剂量胸部CT筛查的风险，获益以及适应证更新的相关证据，并依据最新证据提出了肺癌筛查的建议。 , cover=, journalId=null, articlesId=null, associationId=180, associationName=美国胸科医师学会, associationIntro=提供胸科疾病指南, 《chest》是美国胸科医师学会旗下期刊。, copyright=0, guiderPublishedTime=Sun Apr 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>再过去的几年里，低剂量胸部CT检查已经成为美国肺癌筛查的一种标准的措施。本文基于低剂量胸部CT筛查的风险，获益以及适应证更新的相关证据，并依据最新证据提出了肺癌筛查的建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>肺癌</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=54b8c1c0015e8849" title="2018 ASTRO循证指南：非小细胞肺癌姑息胸部放疗（更新版）" target=_blank>2018 ASTRO循证指南：非小细胞肺癌姑息胸部放疗（更新版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=d14321c0015e631d" title="2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义" target=_blank>2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1acf21c001568a59" title="中国肺癌低剂量螺旋CT筛查指南（2018年版）" target=_blank>中国肺癌低剂量螺旋CT筛查指南（2018年版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=61b921c0015593c2" title="NCCN临床实践指南：非小细胞肺癌（2018.V3）" target=_blank>NCCN临床实践指南：非小细胞肺癌（2018.V3）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=4c45f1c00153a02f" title="NCCN临床实践指南：非小细胞肺癌（2018.V2）" target=_blank>NCCN临床实践指南：非小细胞肺癌（2018.V2）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%BA%E7%99%8C" target=_blank>有关肺癌更多指南</a></ul>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=636, tagName=筛查)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6133, appHits=302, showAppHits=0, pcHits=3847, showPcHits=2616, likes=111, shares=8, comments=4, approvalStatus=1, publishedTime=Sat Apr 21 20:58:13 CST 2018, publishedTimeString=2018-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 21 20:58:13 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 03:11:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CHEST指南：肺癌筛查)])
2018 CHEST指南：肺癌筛查
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=309487, encodeId=80be30948e35, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:30:20 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308056, encodeId=796530805692, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 22 00:53:42 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308018, encodeId=b5d330801825, content=学习指南.指导临床.., beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Apr 21 23:58:43 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307996, encodeId=2e3230e996fe, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 21 22:53:15 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-26 大爰

    学习并分享!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=309487, encodeId=80be30948e35, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:30:20 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308056, encodeId=796530805692, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 22 00:53:42 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308018, encodeId=b5d330801825, content=学习指南.指导临床.., beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Apr 21 23:58:43 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307996, encodeId=2e3230e996fe, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 21 22:53:15 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-22 秀红

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=309487, encodeId=80be30948e35, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:30:20 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308056, encodeId=796530805692, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 22 00:53:42 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308018, encodeId=b5d330801825, content=学习指南.指导临床.., beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Apr 21 23:58:43 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307996, encodeId=2e3230e996fe, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 21 22:53:15 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 1e0f8808m18(暂无匿称)

    学习指南.指导临床..

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=309487, encodeId=80be30948e35, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:30:20 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308056, encodeId=796530805692, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 22 00:53:42 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308018, encodeId=b5d330801825, content=学习指南.指导临床.., beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Apr 21 23:58:43 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307996, encodeId=2e3230e996fe, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 21 22:53:15 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 张新亮1853311252142e2fm

    好文献.学习了

    0

相关指南

2017年UICC/AJCC 第8版肺癌/食管癌TNM分期标准

国际抗癌联盟(UICC,Union for International Cancer Control) · 2017-07-05

2017 ASTRO循证指南：早期非小细胞肺癌的立体放射治疗

暂未更新 · 2017-06-12

回生口服液用于非小细胞肺癌围手术期抗凝治疗专家共识（2016版）

中国肿瘤科相关专家小组（统称） · 2016-11-01

2016 中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识

中华医学会病理学分会 · 2016-04-30

2014 IASLC/ASCO：肺癌患者表皮生长因子受体和间变性淋巴瘤激酶酪氨酸激酶抑制剂的选择性分子检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-31

中国晚期原发性肺癌诊治专家共识(2016年版)

暂未更新 · 2016-04-21

Baidu
map
Baidu
map
Baidu
map